Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03518515
Other study ID # IRB-300001187
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2, 2018
Est. completion date March 18, 2020

Study information

Verified date May 2020
Source University of Alabama at Birmingham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A randomized, clinical trial will be performed to assess changes in body weight and fat mass with daily potato consumption versus a calorie-matched snack of almonds.


Description:

This is a 30-day randomized, controlled trial with 3 arms: 1) non-potato food (almonds), 2) standard white potato French fry, 3) standard white potato French fry with potential glycemia-modulating spice/seasoning mix added.

Free-living study participants will be assigned to consume one of the 3 foods (calorie matched) each day for a 30-day period. Body composition (via dual energy x-ray absorptiometry; DXA), and blood chemistry will be assayed at baseline and study completion, along with a sub-sample of subjects participating in a meal-based tolerance tests at study completion.


Recruitment information / eligibility

Status Completed
Enrollment 180
Est. completion date March 18, 2020
Est. primary completion date March 18, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- 18- 50 years old

- Body mass index (BMI) 20- 35

- No dietary restrictions or allergies

- Weight stable

- Access to camera through smartphone, computer or tablet

Exclusion Criteria:

- Pregnancy or anticipating pregnancy or lactation

- Nut or food allergy

- Diagnosed diabetes (Type 1 or 2)

- History of weight control surgery (bariatric or liposuction)

- Consumes >1 serving of potatoes daily before enrollment

- Weight loss or gain >5% within past 6 months

- Medical conditions or medications that would prevent the ability to comply with treatment assignment and/or affect energy balance

- Dependence on others for food procurement or preparation

Study Design


Related Conditions & MeSH terms


Intervention

Other:
White potato (french fries)
If randomized to this group, participants will be asked to consume 1 serving of French fries (~300 kcal) each day for 30 days as a part of their usual dietary intake. French fries will be portioned and provided to participants.
White potato (French fries), +seasoning
If randomized to this group, participants will be asked to consume 1 serving of French fries (~300 kcal) with added potential glycemia modifying seasoning mix each day for 30 days as a part of their usual dietary intake. French fries and seasoning will be portioned and provided to participants.
Almond
If randomized to this group, participants will be asked to consume 1 serving of almonds that is calorically-matched to the French fries (~300 kcal) serving in the other arms each day for 30 days as a part of their usual dietary intake. Almonds will be portioned and provided to participants.

Locations

Country Name City State
United States University of Alabama at Birmingham Birmingham Alabama

Sponsors (3)

Lead Sponsor Collaborator
University of Alabama at Birmingham Alliance for Potato Research and Education, Indiana University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in fat mass Determined by dual-energy X-ray absorptiometry. baseline and study completion (30 days)
Secondary Change in body weight baseline and study completion (30 day)
Secondary Change in fasting glucose baseline and study completion (30 day)
Secondary Change in fasting insulin baseline and study completion (30 day)
Secondary Change in HbA1c baseline and study completion (30 day)
Secondary Change in caloric Intake Dietary recall by 3 day food record. baseline and study completion (30 days)
Secondary Meal Tolerance Test A subset of subjects from each diet group will participate in a meal-based tolerance test with the study food items. Study Completion (30 day)
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2